newsfilter
← Latest News
GlobeNewswire·

89bio Announces Closing of its Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

SAN FRANCISCO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. ("89bio") (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the